
|Articles|March 20, 2006
Newsbriefs
New software and hardware
Advertisement
New software and hardware
Highlighting hypertension
Fibrinolytics before surgery questioned
Rather than helping patients, clot-busters given to heart attack patients before an angioplasty is performed may actually increase the risk of subsequent myocardial infarctions and strokes. These are the conclusions of several studies published in the Feb. 18 issue of the Lancet. The findings are expected to provoke a review by the medical community of the practice of administering anticlotting drugs to facilitate an angioplasty.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Pneumococcal Vaccination at 50 Years Old Can Improve Outcomes
5





























































